HIV clinical stages and lower extremity arterial disease among HIV infected outpatients in Burundi

Abstract Chronic disease of people living with human immunodeficiency virus (HIV) infection are now approaching those of the general population. Previous, in vitro studies shown that HIV causes arterial injuries resulting in inflammation and atherosclerosis but direct relationship between HIV infect...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ileana Desormais, Deo Harimenshi, Théodore Niyongabo, Philippe Lacroix, Victor Aboyans, Pierre Marie Preux
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/573265a69009485cba6788c1d1edb9ac
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:573265a69009485cba6788c1d1edb9ac
record_format dspace
spelling oai:doaj.org-article:573265a69009485cba6788c1d1edb9ac2021-12-02T14:27:56ZHIV clinical stages and lower extremity arterial disease among HIV infected outpatients in Burundi10.1038/s41598-021-87862-z2045-2322https://doaj.org/article/573265a69009485cba6788c1d1edb9ac2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87862-zhttps://doaj.org/toc/2045-2322Abstract Chronic disease of people living with human immunodeficiency virus (HIV) infection are now approaching those of the general population. Previous, in vitro studies shown that HIV causes arterial injuries resulting in inflammation and atherosclerosis but direct relationship between HIV infection clinical stages and lower extremity arterial disease (LEAD) remain controversial. No study assessed, with an accurate method, both the prevalence of LEAD and the influence of HIV severity on LEAD in HIV outpatients in Central Africa. A cross-sectional study was conducted among 300 HIV-infected outpatients, aged ≥ 40 years in Bujumbura, Burundi. All patients underwent ankle-brachial index (ABI) measurement and LEAD was diagnosed by ABI ≤ 0.9. The prevalence of LEAD was 17.3% (CI 95% 13.2–22.1). The mean age was 49.6 ± 7.1 years. On multivariable analysis, factors associated with LEAD were hypertension (OR = 2.42; 95% CI 1.10–5.80), and stage IV HIV clinical infection (OR = 4.92, 95% CI 1.19–20.36). This is the first study performed on a large HIV population in Central Africa, reporting high LEAD prevalence. It underlines the influence of HIV infection on peripheral atherosclerosis at latest clinical stages and the need for LEAD screening in HIV-infected patients.Ileana DesormaisDeo HarimenshiThéodore NiyongaboPhilippe LacroixVictor AboyansPierre Marie PreuxNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ileana Desormais
Deo Harimenshi
Théodore Niyongabo
Philippe Lacroix
Victor Aboyans
Pierre Marie Preux
HIV clinical stages and lower extremity arterial disease among HIV infected outpatients in Burundi
description Abstract Chronic disease of people living with human immunodeficiency virus (HIV) infection are now approaching those of the general population. Previous, in vitro studies shown that HIV causes arterial injuries resulting in inflammation and atherosclerosis but direct relationship between HIV infection clinical stages and lower extremity arterial disease (LEAD) remain controversial. No study assessed, with an accurate method, both the prevalence of LEAD and the influence of HIV severity on LEAD in HIV outpatients in Central Africa. A cross-sectional study was conducted among 300 HIV-infected outpatients, aged ≥ 40 years in Bujumbura, Burundi. All patients underwent ankle-brachial index (ABI) measurement and LEAD was diagnosed by ABI ≤ 0.9. The prevalence of LEAD was 17.3% (CI 95% 13.2–22.1). The mean age was 49.6 ± 7.1 years. On multivariable analysis, factors associated with LEAD were hypertension (OR = 2.42; 95% CI 1.10–5.80), and stage IV HIV clinical infection (OR = 4.92, 95% CI 1.19–20.36). This is the first study performed on a large HIV population in Central Africa, reporting high LEAD prevalence. It underlines the influence of HIV infection on peripheral atherosclerosis at latest clinical stages and the need for LEAD screening in HIV-infected patients.
format article
author Ileana Desormais
Deo Harimenshi
Théodore Niyongabo
Philippe Lacroix
Victor Aboyans
Pierre Marie Preux
author_facet Ileana Desormais
Deo Harimenshi
Théodore Niyongabo
Philippe Lacroix
Victor Aboyans
Pierre Marie Preux
author_sort Ileana Desormais
title HIV clinical stages and lower extremity arterial disease among HIV infected outpatients in Burundi
title_short HIV clinical stages and lower extremity arterial disease among HIV infected outpatients in Burundi
title_full HIV clinical stages and lower extremity arterial disease among HIV infected outpatients in Burundi
title_fullStr HIV clinical stages and lower extremity arterial disease among HIV infected outpatients in Burundi
title_full_unstemmed HIV clinical stages and lower extremity arterial disease among HIV infected outpatients in Burundi
title_sort hiv clinical stages and lower extremity arterial disease among hiv infected outpatients in burundi
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/573265a69009485cba6788c1d1edb9ac
work_keys_str_mv AT ileanadesormais hivclinicalstagesandlowerextremityarterialdiseaseamonghivinfectedoutpatientsinburundi
AT deoharimenshi hivclinicalstagesandlowerextremityarterialdiseaseamonghivinfectedoutpatientsinburundi
AT theodoreniyongabo hivclinicalstagesandlowerextremityarterialdiseaseamonghivinfectedoutpatientsinburundi
AT philippelacroix hivclinicalstagesandlowerextremityarterialdiseaseamonghivinfectedoutpatientsinburundi
AT victoraboyans hivclinicalstagesandlowerextremityarterialdiseaseamonghivinfectedoutpatientsinburundi
AT pierremariepreux hivclinicalstagesandlowerextremityarterialdiseaseamonghivinfectedoutpatientsinburundi
_version_ 1718391252743880704